Publication | Closed Access

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

HepatologyViral HepatitisHepatitis BHepatitisAntiviral TherapyAnticoagulantPharmacotherapyNon-inferiority TrialAntiviral DrugMedicineTenofovir Disoproxil FumaratePhase 3